New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For KKR;CG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
12:56 EDTKKRKKR's Samson in restructuring talks, WSJ says
KKR's (KKR) Samson Resources is in discussions with restructuring advisers at Blackstone (BX) and other firms on how to handle its $3.8B long-term debt, reports the Wall Street Journal, citing people familiar with the matter. The Journal notes that Samson previously expressed interest in selling some oil and gas fields. Reference Link
February 24, 2015
15:07 EDTCGCarlyle, Cap Gemini talks to buy CSC have 'fizzled,' Reuters says
Consulting company Cap Gemini and private equity firm Carlyle Group (CG) previously held talks about a potential acquisition of Computer Sciences Corp. (CSC), though the talks have since "fizzled," reported Reuters, citing people familiar with the matter. CSC is now working with Royal Bank of Canada (RY) to review its options, the report added. Reference Link
14:56 EDTCGCarlyle, Cap Gemini talks to buy CSC have 'fizzled,' Reuters says
Subscribe for More Information
February 23, 2015
13:49 EDTCGCarlyle Group, Advent mull sale of H.C. Starck, Bloomberg reports
Subscribe for More Information
February 20, 2015
06:29 EDTKKRBayer close to selling diabetes unit to Panasonic, Bloomberg says
Subscribe for More Information
February 19, 2015
14:53 EDTKKRBayer near sale of diabetes unit to KKR backed venture, Bloomberg says
Subscribe for More Information
14:01 EDTKKRBayer near sale of diabetes unit to KKR's Panasonic Healthcare, Bloomberg says
Subscribe for More Information
February 18, 2015
10:05 EDTCGOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Agnico Eagle (AEM) upgraded to Overweight from Neutral at JPMorgan... Amarin (AMRN) upgraded to Buy from Neutral at SunTrust... Capital Product (CPLP) upgraded to Accumulate from Neutral at Global Hunter... Carlyle Group (CG) upgraded to Buy from Neutral at Citigroup... Danone (DANOY) upgraded to Neutral from Underperform at Exane BNP Paribas... Express (EXPR) upgraded on lower promotional activity at Piper Jaffray... Kforce (KFRC) upgraded to Outperform from Market Perform at Avondale... Legg Mason (LM) upgraded to Buy from Hold at Jefferies... Rackspace (RAX) upgraded following Q4 results at Pacific Crest... Rosetta Resources (ROSE) upgraded to Buy from Neutral at Global Hunter... SeaChange (SEAC) upgraded to Buy from Hold at Noble Financial... Valero (VLO) upgraded to Outperform from Neutral at Credit Suisse... Veeco (VECO) upgraded to Buy from Hold at Noble Financial... Wolverine World Wide (WWW) upgraded to Neutral from Underperform at Sterne Agee.
06:08 EDTCGCarlyle Group upgraded to Buy from Neutral at Citigroup
Citigroup upgraded Carlyle Group to Buy saying it believes the company is entering a "robust" harvesting cycle. Citi says Carlyle is at a favorable inflection point and raised its price target for the stock to $32 from $30.50.
06:03 EDTKKRAllen Systems Group reaches agreement with senior lenders on debt restructuring
Subscribe for More Information
February 13, 2015
09:21 EDTCGOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Cytokinetics (CYTK), up 15.6%... King Digital (KING), up 22.2%... Cyberark Software (CYBR), up 19.2%... Web.com (WWWW), up 4%... CBS (CBS), up 3.4%. ALSO HIGHER: Freescale Semiconductor (FSL), up 10.9% following a New York Post report that the company is exploring a sale. Carlyle Group (CG), which owns Freescale, along with Blackstone (BX), is up 1.5%. Blackstone is up fractionally... Whiting Petroleum (WLL), up 4.4% following a Bloomberg report that the company is seeking a buyer for assets in North Dakota... Ariad Pharmaceuticals (ARIA), up 5.7% following a CNBC report that Sarissa Capital is seeking to replace Ariad CEO and Chairman Harvey Berger. DOWN AFTER EARNINGS: Knowles (KN), down 20.3%... Zynga (ZNGA). down 12.4%... J.M. Smucker (SJM), down 2.1%. ALSO LOWER: Magnachip Semiconductor (MX), down 51.7% after restating financial results... Idera Pharmaceuticals (IDRA), down 7.6% after 20M share Secondary priced at $3.75.
07:10 EDTCGFreescale said to be exploring a sale, NY Post reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use